期刊文献+

2型糖尿病患者幽门螺杆菌再感染因素分析 被引量:5

Analysis of the influencing factors of helicobacter pylori reinfection in patients with type 2 diabetes
下载PDF
导出
摘要 目的研究2型糖尿病(T2DM)患者四联抗幽门螺杆菌(HP)根除治疗48周后再感染影响因素。方法纳入我院内分泌科住院的T2DM患者179例,经13C尿素呼气试验检测HP阳性者108例,予以患者四联抗HP治疗2周,停药后4周复查HP阴性者97例继续随访,48周时再次复查HP;根据48周复测结果分为HP再感染阳性(H P阳性)组与HP再感染阴性(H P阴性)组。比较2组年龄、性别、体质量指数(BMI)、糖化血红蛋白(H bA1c)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)、总胆固醇(TC)、高密度脂蛋白胆固醇(H DL-C)、血尿酸(U A)、糖尿病(D M)病程、是否使用胰岛素、月收入≥3000元、吸烟史及饮酒史等指标的差异;探讨各个变量对HP再感染的影响。结果 T2DM患者中HP感染率为60.3%( 108/179);4周时HP根除率为89.8%( 97/108), 48周时HP再感染率为23.7%( 23/97);HP阳性组的DM病程、HbA1c均高于HP阴性组,HP阴性组的月收入≥3000元患者比例高于HP阳性组(P< 0.05);余指标2组差异无统计学意义(P> 0.05)。二分类Logistic回归分析结果显示,DM病程较长(OR=1.195, 95%C:I1.049~1.136)、 HbA1c升高(OR=1.293, 95%CI1.011~1.518)是 HP再感染的危险因素。结论在T2DM人群中存在HP再感染,DM病程越长及HbA1c越高者HP再感染可能性越大。 Objective To analyze the influencing factors of helicobacter pylori (HP) reinfection in patients with type 2 diabetes mellitus (T2DM) 48 weeks after a successful standard eradicating treatment. Methods A total of 179 T2DM patients from endocrine department of our hospital were included in our study. Among them 108 patients were evaluated HP infection by means of 13C-Urea Breath Test. All positive patients were eradicated by means of a standard quadruple therapy for 2 weeks. The eradication of HP was confirmed by means of 13C-Urea Breath Test performed at least four weeks after therapy, and 97 patients were successfully eradicated. After 48 weeks of follow-up, 97 patients underwent another 13C-Urea Breath Test. It was found that 74 out of 97 patients were negative and 23 positive for HP reinfection. The clinical data of 97 patients were collected and compared between two groups (HP negative group and HP positive group), including age, sex, body mass index (BMI), hemoglobin A1c (HbA1c), triglyceride (TG), low density lipoprotein cholesterol (LDL-C), total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), Uric acid (UA), the duration of diabetes mellitus (DM), insulin usage, socio-economic status (monthly income ≥ 3 000 yuan) and the history of smoking and drinking. The effects of these variables on HP reinfection were also evaluated. Results The prevalence of HP was 60.3%(108 / 179). The eradication rate of HP was 89.8%(97/108). The reinfection rate was 23.7%(23/97) after 48-week of follow-up. The duration of DM and the level of HbA1c were significantly higher, and the proportion of patients with monthly income ≥3 000 yuan was significantly lower in HP positive group than those of HP negative group (P< 0.05). There were no significant differences in other indexes between two groups (P> 0.05). Binary logistic regression analysis showed that the duration of DM (OR=1.195, 95%CI 1.049-1.136) and the level of HbA1c (OR=1.293, 95%CI 1.011~1.518) were risk factors of HP reinfection. Conclusion According to our data, there is HP reinfection in T2DM patients. The long duration of DM and high level of HbA1c are associated with HP reinfection.
作者 田利华 薛亚男 谢军 TIAN Li-hua;XUE Ya-nan;XIE Jun(Qinhuangdao Jungong Hospital, Qinhuangdao 066000, China;Hebei Port Group Co.,Ltd. Port Hospital)
出处 《天津医药》 CAS 北大核心 2019年第5期525-528,共4页 Tianjin Medical Journal
关键词 螺杆菌 幽门 螺杆菌感染 糖尿病 2型 血红蛋白A 糖基化 危险因素 helicobacter pylori helicobacter infections diabetes mellitus, type 2 hemoglobin A, glycosylated risk factors
  • 相关文献

参考文献6

二级参考文献85

  • 1Kum Hei Ryu,Sun Young Yi,Youn Ju Na,Su Jung Baik,Su Jin Yoon,Hae-Sun Jung,Hyun Joo Song.Reinfection rate and endoscopic changes after successful eradication of Helicobacter pylori[J].World Journal of Gastroenterology,2010,16(2):251-255. 被引量:14
  • 2Bin Lu Ming-Tao Chen Yi-Hong Fan Yan Liu Li-Na Meng.Effects of Helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia: A 3-year follow-up study[J].World Journal of Gastroenterology,2005,11(41):6518-6520. 被引量:27
  • 3王艳军,何冰,李晓东.TNF-α、IL-6、NO在高血压胰岛素抵抗患者血浆中的变化及意义[J].中国医科大学学报,2006,35(5):525-526. 被引量:9
  • 4King H,Aubert RE,Herman WH.Global burden of diabetes,1995-2025:prevalence,numerical estimates,and projections.Diabetes Care,1998,21:1414-1431.
  • 5Stovring H,Andersen M,Beck-Nielsen H,et al.Rising prevalence of diabetes:evidence from a Danish pharmacy-epidemiolngical database.Lancet,2003,362:537-538.
  • 6Silverman DT,Schiffman M,Everhart J,et al.Diabetes mellitus,other medical conditions and familial history of cancer as risk factors for pancreatic cancer.Br J Cancer,1999,80:1830-1837.
  • 7Yang YX,Hennessy S,Lewis JD.Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients.Gastroenterology,2004,127:1044-1050.
  • 8Bayram A,Eksi F,Mehli M.Prevalence of hepatitis E virus antibodies in patients with chronic hepatitis B and chronic hepatitis C.Gastroenterology,2008,134:95-101.
  • 9Larsson SC,Mantzoros CS,Wolk A.Diabetes mellitus and risk of breast cancer:a meta-analysis.Int J Cancer,2007,121:856-862.
  • 10Yancik R,Wesley MN,Ries LA,et al.Effect of age and comorbidity in postmenopansal breast cancer patients aged 55 years and older.JAMA,2001,285:885-892.

共引文献133

同被引文献56

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部